clinical trials glp-1 Real-World Evidence for Receptor Agonists Across the CKD Spectrum – AJKD Blog Advancing Clinical Research in GLP-1

What they found was cost dominates treatment decisions: 68% said cost influenced their decision to start or continue treatment 44% said the medication cost more than they expected Cost surpassed side effects as the #1 reason people stopped taking GLP-1s A breakdown of the financial burden: 24% pay more than $250 per prescription fill Nearly 8% pay $500 or more per fill 24% said insurance didn't cover any cost Weight management patients were nearly twice as likely to pay $250+ vs diabetes patients --- Here's what patients are thinking: Nearly 40% ended up using discount programs or manufacturer coupons 60% know someone who wants GLP-1s but can't afford them 83% believe Americans turn to DTC programs because traditional healthcare is too expensive Patients still prioritize safety: 60% are aware of safety risks with non-FDA-approved GLP-1s--this one surprised me

One of the most common concerns I hear is about side effectsespecially stomach upset, loss of appetite, or wh

Please double-check that youve selected the correct ePass at checkout

Ozempic has quickly become a household name due to its powerful results in diabetes management and weight loss

Includes medication, clinician care, 1:1 coaching & Noom Weight program

Medical Weight Loss with GLP-1s: What They Are, How They Work, and Whether Theyre Right for You GLP-1 medications such as semaglutide and tirzepatide have become some of the most talked-about tools in medical weight loss and metabolic health